Irisin has antioxidative, anti-inflammatory, and antiapoptotic effects, which indicates its potential as a therapeutic and diagnostic target for diabetes, obesity, nonalcoholic fatty liver disease, osteoporosis, and even cancer [10, 12, 13]. Here, FNDC5 is linked to obesity due to melanocortin 4 receptor deficiency.